These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9761155)

  • 21. Low Third-Trimester Serum Levels of Lamivudine/Zidovudine and Lopinavir/Ritonavir in an HIV-Infected Pregnant Woman with Gastric Bypass.
    Michalik DE; Jackson-Alvarez JT; Flores R; Tolentino-Baldridge C; Batra JS
    J Int Assoc Provid AIDS Care; 2015; 14(2):116-9. PubMed ID: 25361558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incorporation of zidovudine into cord blood DNA of infants and peripheral blood DNA of their HIV-1-positive mothers.
    Olivero OA; Shearer GM; Chougnet CA; Kovacs AA; Baker R; Stek AM; Khoury MM; Poirier MC
    Ann N Y Acad Sci; 2000 Nov; 918():262-8. PubMed ID: 11131712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of didanosine and drug resistance mutations in infants exposed to zidovudine during gestation or postnatally and treated with didanosine or zidovudine in the first three months of life.
    Kovacs A; Cowles MK; Britto P; Capparelli E; Fowler MG; Moye J; McIntosh K; Rathore MH; Pitt J; Husson RN
    Pediatr Infect Dis J; 2005 Jun; 24(6):503-9. PubMed ID: 15933559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-1 genotypic zidovudine drug resistance and the risk of maternal--infant transmission in the women and infants transmission study. The Women and Infants Transmission Study Group.
    Welles SL; Pitt J; Colgrove R; McIntosh K; Chung PH; Colson A; Lockman S; Fowler MG; Hanson C; Landesman S; Moye J; Rich KC; Zorrilla C; Japour AJ
    AIDS; 2000 Feb; 14(3):263-71. PubMed ID: 10716502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recommendations of the U.S. Public Health Service Task Force on the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus.
    MMWR Recomm Rep; 1994 Aug; 43(RR-11):1-20. PubMed ID: 7913986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
    Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
    Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Zidovudine, lamivudine, and nelfinavir concentrations in amniotic fluid and maternal serum.
    Bennetto-Hood C; Bryson YJ; Stek A; King JR; Mirochnick M; Acosta EP
    HIV Clin Trials; 2009; 10(1):41-7. PubMed ID: 19362995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implications of the kinetics of zidovudine in the pregnant baboon following oral administration.
    Garland M; Szeto HH; Daniel SS; Tropper PJ; Myers MM; Stark RI
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(5):433-40. PubMed ID: 9859956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of oral zidovudine administered during labour: a preliminary study.
    Mirochnick M; Rodman JH; Robbins BL; Fridland A; Gandía J; Hitti J; Bardeguez A; Rathore MH; Gonzalez Garcia A; Cababasay M; Samson P; Mofenson L; Bryson YJ; Dorenbaum A
    HIV Med; 2007 Oct; 8(7):451-6. PubMed ID: 17760737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Missed opportunities for perinatal HIV prevention among HIV-exposed infants born 1996-2000, pediatric spectrum of HIV disease cohort.
    Peters V; Liu KL; Dominguez K; Frederick T; Melville S; Hsu HW; Ortiz I; Rakusan T; Gill B; Thomas P
    Pediatrics; 2003 May; 111(5 Pt 2):1186-91. PubMed ID: 12728136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Estimate of HIV-1 infection prevalence in pregnant women and effectiveness of zidovudine administered during pregnancy in the prevention of vertical transmission].
    Ramos Amador JT; Contreras JR; Bastero R; Barrio C; Moreno P; Delgado R; Muñoz E; Jiménez J
    Med Clin (Barc); 2000 Mar; 114(8):286-91. PubMed ID: 10774515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV infection and zidovudine use in childbearing women.
    Sia J; Paul S; Martin RM; Cross H
    Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of zidovudine use in HIV-infected pregnant women on vertical transmission of HIV in Mississippi.
    Palmer AL; Gay H; Currier MM
    J Miss State Med Assoc; 2000 Feb; 41(2):479-83. PubMed ID: 10710894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hematological effects of zidovudine prophylaxis in newborn infants with and without prenatal exposure to zidovudine.
    Baroncelli S; Pinnetti C; Genovese O; Tamburrini E; Floridia M
    J Med Virol; 2011 Mar; 83(3):551-6. PubMed ID: 21264878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrapartum use of zidovudine in a large cohort of pregnant women living with HIV in Italy.
    Taramasso L; Bovis F; Di Biagio A; Mignone F; Giaquinto C; Tagliabue C; Giacomet V; Genovese O; Chiappini E; Salomè S; Badolato R; Carloni I; Cellini M; Dodi I; Bossi G; Allodi A; Bernardi S; Consolini R; Dedoni M; Banderali G; Mazza A; Pruccoli G; Rampon O; Erba P; Di Pietro G; Montagnani C; Capasso L; Dotta L; Zallocco F; De Martino M; Lisi C; Tovo PA; Bassetti M; Gabiano C; Galli L;
    J Infect; 2022 Nov; 85(5):565-572. PubMed ID: 35987392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of intensive nurse case management in decreasing vertical transmission of human immunodeficiency virus infection in Wisconsin.
    Havens PL; Cuene BE; Hand JR; Gern JE; Sullivan BW; Chusid MJ
    Pediatr Infect Dis J; 1997 Sep; 16(9):871-5. PubMed ID: 9306482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of maternal use of antiretroviral agents on serum insulin levels of the newborn infant.
    El Beitune P; Duarte G; Foss MC; Montenegro RM; Quintana SM; Figueiró-Filho EA; Nogueira AA
    Diabetes Care; 2005 Apr; 28(4):856-9. PubMed ID: 15793185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of opioid dependence pharmacotherapies on zidovudine disposition.
    McCance-Katz EF; Rainey PM; Friedland G; Kosten TR; Jatlow P
    Am J Addict; 2001; 10(4):296-307. PubMed ID: 11783744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment failure of preventive zidovudine in maternal fetal transmission of HIV].
    Wirtgen P; Pons JC; Boubon MC; Taburet AM; Delfraissy JF; Horovitz J
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(3):289-92. PubMed ID: 8102148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.